The Clinical Analysis of Mifepristone Treatment in Dysfunctional Uterine Bleeding Menopause after Diagnostic Curettage

Objective: By observing the diagnostic curettage mifepristone treatment of dysfunctional uterine bleeding after menopause,the analysis of its clinical efficacy.Method: Patients were divided into observation group and control group,then observation group after diagnostic curettage treated with mifepristone,the control group treated only with diagnostic curettage.By monitoring the hormone FSH,LH,PRL,E2 levels,HGB value,uterine B-ultrasound,menstrual changes,and adverse reactions occurred during follow-up observation and evaluation of recurrence,efficacy of two methods.Result: FSH levels were significantly different before and after treatment,P 0.05;E2 levels were significantly different,P 0.01;endometrial thickness and changes in HGB values were highly significant differences,P 0.01.Compared two groups after treatment: Endometrial thickness and HGB values were significantly different,P 0.05;into menopause who have a very significant difference,P 0.01;resume normal menstruation and menorrhagia or menstrual elderly persons.There was a significant difference,P 0.05;recurrence during follow-up on the two groups were significantly different,P 0.05;there was no damage to liver and kidney function significantly different,P 0.05.Conclusion: Curettage after mifepristone treatment and diagnosis of dysfunctional uterine bleeding menopause good efficacy,side effects light,low recurrence rate,is an ideal treatment.